These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1623905)

  • 1. Divergent effects of different enzyme-inducing agents on endogenous and exogenous testosterone.
    Bammel A; van der Mee K; Ohnhaus EE; Kirch W
    Eur J Clin Pharmacol; 1992; 42(6):641-4. PubMed ID: 1623905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of urinary 6-beta-hydroxycortisol excretion as an in vivo parameter in the clinical assessment of the microsomal enzyme-inducing capacity of antipyrine, phenobarbitone and rifampicin.
    Ohnhaus EE; Park BK
    Eur J Clin Pharmacol; 1979 Mar; 15(2):139-45. PubMed ID: 35353
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of antipyrine, phenobarbitol and rifampicin on thyroid hormone metabolism in man.
    Ohnhaus EE; Bürgi H; Burger A; Studer H
    Eur J Clin Invest; 1981 Oct; 11(5):381-7. PubMed ID: 6800809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme-inducing drug combinations and their effects on liver microsomal enzyme activity in man.
    Ohnhaus EE; Gerber-Taras E; Park BK
    Eur J Clin Pharmacol; 1983; 24(2):247-50. PubMed ID: 6840175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of antipyrine and rifampicin on the excretion of renal enzymes in human urine.
    Wensing G; Maruhn D; Ohnhaus EE
    Clin Nephrol; 1988 Feb; 29(2):69-74. PubMed ID: 2896083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary excretion of 6 beta-hydroxycortisol and the time course measurement of enzyme induction in man.
    Ohnhaus EE; Breckenridge AM; Park BK
    Eur J Clin Pharmacol; 1989; 36(1):39-46. PubMed ID: 2917586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of rifampicin, phenobarbital and cimetidine on mixed function monooxygenase in extensive and poor metabolizers of debrisoquine.
    Leclercq V; Desager JP; Horsmans Y; Van Nieuwenhuyze Y; Harvengt C
    Int J Clin Pharmacol Ther Toxicol; 1989 Dec; 27(12):593-8. PubMed ID: 2613393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of enzyme induction on plasma lipids using antipyrine, phenobarbital, and rifampicin.
    Ohnhaus EE; Kirchhof B; Peheim E
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 1):591-7. PubMed ID: 35298
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative effects of rifabutin and rifampicin on hepatic microsomal enzyme activity in normal subjects.
    Perucca E; Grimaldi R; Frigo GM; Sardi A; Mönig H; Ohnhaus EE
    Eur J Clin Pharmacol; 1988; 34(6):595-9. PubMed ID: 2901960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of antipyrine and phenobarbital on renal gamma-glutamyltransferase excretion in human urine.
    Wensing G; Neumann U; Ohnhaus EE; Heidemann HT
    Clin Pharmacol Ther; 1990 Nov; 48(5):575-81. PubMed ID: 1977543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of antipyrine and sulphadimidine in dwarf goats: effects of the enzyme-inducing agents phenobarbital, troleandomycin and rifampicin.
    Natsuhori M; Witkamp RF; Van 't Klooster GA; Van Miert AS
    Xenobiotica; 1992 Nov; 22(11):1243-50. PubMed ID: 1492417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A link between liver microsomal enzyme activity and thyroid hormone metabolism in man.
    Ohnhaus EE; Studer H
    Br J Clin Pharmacol; 1983 Jan; 15(1):71-6. PubMed ID: 6849748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo oxidative biotransformation in the West-African dwarf goat (Caprus hircus aegagrus): substrate activities and effects of inducers.
    Zweers-Zeilmaker WM; Batzias J; Maas RF; Horbach GJ; van Miert AS; Witkamp RF
    Xenobiotica; 1996 Nov; 26(11):1131-41. PubMed ID: 8948089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme induction and renal function in man.
    Ohnhaus EE; Martin J; Kinser J; Colombo JP
    Br J Clin Pharmacol; 1977 Feb; 4(1):33-7. PubMed ID: 843422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of enzyme induction on polymorphic sparteine oxidation.
    Eichelbaum M; Mineshita S; Ohnhaus EE; Zekorn C
    Br J Clin Pharmacol; 1986 Jul; 22(1):49-53. PubMed ID: 3741726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of antipyrine and rifampin on the metabolism of diazepam.
    Ohnhaus EE; Brockmeyer N; Dylewicz P; Habicht H
    Clin Pharmacol Ther; 1987 Aug; 42(2):148-56. PubMed ID: 3608348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of enzyme induction on diazepam metabolism in man.
    Ohnhaus EE; Park BK; Colombo JP; Heizmann P
    Br J Clin Pharmacol; 1979 Dec; 8(6):557-63. PubMed ID: 42427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of low-dose phenobarbitone on three indices of hepatic microsomal enzyme induction.
    Price DE; Mehta A; Park BK; Hay A; Feely MP
    Br J Clin Pharmacol; 1986 Dec; 22(6):744-7. PubMed ID: 3567022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of liver microsomal enzyme inducing and inhibiting drugs on insulin mediated glucose metabolism in man.
    Lahtela JT; Gachalyi B; Eksymä S; Hämäläinen A; Sotaniemi EA
    Br J Clin Pharmacol; 1986 Jan; 21(1):19-26. PubMed ID: 3511933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of phenobarbital and spironolactone treatment on the oxidative metabolism of antipyrine by rat liver microsomes.
    Szakács T; Veres Z; Vereczkey L
    Pol J Pharmacol; 2001; 53(1):11-9. PubMed ID: 11785906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.